Marks JR - Search Results

1

Molecular signatures of epithelial ovarian cancer: analysis of associations with tumor characteristics and epidemiologic risk factors.

Schildkraut JM, Iversen ES, Akushevich L, Whitaker R, Bentley RC, Berchuck A, Marks JR. Schildkraut JM, et al. Among authors: marks jr. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1709-21. doi: 10.1158/1055-9965.EPI-13-0192. Epub 2013 Aug 5. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23917454 Free PMC article.

2

The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cells.

Boente MP, Berchuck A, Rodriguez GC, Davidoff A, Whitaker R, Xu FJ, Marks J, Clarke-Pearson DL, Bast RC Jr. Boente MP, et al. Among authors: marks j. Am J Obstet Gynecol. 1992 Dec;167(6):1877-82. doi: 10.1016/0002-9378(92)91790-h. Am J Obstet Gynecol. 1992. PMID: 1361720

3

Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation.

Jacobs IJ, Kohler MF, Wiseman RW, Marks JR, Whitaker R, Kerns BA, Humphrey P, Berchuck A, Ponder BA, Bast RC Jr. Jacobs IJ, et al. Among authors: marks jr. J Natl Cancer Inst. 1992 Dec 2;84(23):1793-8. doi: 10.1093/jnci/84.23.1793. J Natl Cancer Inst. 1992. PMID: 1433368

4

Overexpression and mutation of p53 in endometrial carcinoma.

Kohler MF, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Iglehart JD, Soper JT, Clarke-Pearson DL, Bast RC Jr, Marks JR. Kohler MF, et al. Among authors: marks jr. Cancer Res. 1992 Mar 15;52(6):1622-7. Cancer Res. 1992. PMID: 1540970

5

p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.

Kerns BJ, Jordan PA, Moore MB, Humphrey PA, Berchuck A, Kohler MF, Bast RC Jr, Iglehart JD, Marks JR. Kerns BJ, et al. Among authors: marks jr. J Histochem Cytochem. 1992 Jul;40(7):1047-51. doi: 10.1177/40.7.1607637. J Histochem Cytochem. 1992. PMID: 1607637

6

Maintenance of p53 alterations throughout breast cancer progression.

Davidoff AM, Kerns BJ, Iglehart JD, Marks JR. Davidoff AM, et al. Among authors: marks jr. Cancer Res. 1991 May 15;51(10):2605-10. Cancer Res. 1991. PMID: 1850660

7

Overexpression and mutation of p53 in epithelial ovarian cancer.

Marks JR, Davidoff AM, Kerns BJ, Humphrey PA, Pence JC, Dodge RK, Clarke-Pearson DL, Iglehart JD, Bast RC Jr, Berchuck A. Marks JR, et al. Cancer Res. 1991 Jun 1;51(11):2979-84. Cancer Res. 1991. PMID: 2032235

8

Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

Iglehart JD, Kraus MH, Langton BC, Huper G, Kerns BJ, Marks JR. Iglehart JD, et al. Among authors: marks jr. Cancer Res. 1990 Oct 15;50(20):6701-7. Cancer Res. 1990. PMID: 2208136

9

Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells.

Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast RC Jr, Iglehart JD, Marks JR. Elbendary A, et al. Among authors: marks jr. Cell Growth Differ. 1994 Dec;5(12):1301-7. Cell Growth Differ. 1994. PMID: 7696178

10

Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.

Liu FS, Kohler MF, Marks JR, Bast RC Jr, Boyd J, Berchuck A. Liu FS, et al. Among authors: marks jr. Obstet Gynecol. 1994 Jan;83(1):118-24. Obstet Gynecol. 1994. PMID: 8272291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

844 results

Search Page

Filters